These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12805255)

  • 1. Synergy, antagonism, and what the chequerboard puts between them.
    Odds FC
    J Antimicrob Chemother; 2003 Jul; 52(1):1. PubMed ID: 12805255
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacologic basis for the use of combinations of antimicrobial drugs.
    Jawetz E
    Pharmacol Physicians; 1967 Jan; 1(1):1-6. PubMed ID: 6037148
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.
    Petersen PJ; Labthavikul P; Jones CH; Bradford PA
    J Antimicrob Chemother; 2006 Mar; 57(3):573-6. PubMed ID: 16431863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Solak S; Willke A; Ergönül O; Tekeli E
    Int J Antimicrob Agents; 2005 Feb; 25(2):181-2. PubMed ID: 15664492
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique.
    Montanari MP; Piccoli L; Mingoia M; Marchetti F; Varaldo PE
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):157-60. PubMed ID: 16168614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug combination: pharmacological and therapeutic problems].
    Borasi M
    Boll Chim Farm; 1970 Jul; 109(7):399-405. PubMed ID: 5491903
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action.
    Laue H; Weiss L; Bernardi A; Hawser S; Lociuro S; Islam K
    J Antimicrob Chemother; 2007 Dec; 60(6):1391-4. PubMed ID: 17962215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evidence of phyto-synergy for plant part combinations of Croton gratissimus (Euphorbiaceae) used in African traditional healing.
    van Vuuren SF; Viljoen AM
    J Ethnopharmacol; 2008 Oct; 119(3):700-4. PubMed ID: 18644430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-mediated augmentation of beta-lactam antibacterial activity against Escherichia coli.
    Goswami M; Jawali N
    J Antimicrob Chemother; 2007 Jul; 60(1):184-5. PubMed ID: 17483144
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug interactions important for periodontal therapy.
    Sims PJ; Sims KM
    Periodontol 2000; 2007; 44():15-28. PubMed ID: 17474923
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
    Młynarczyk A; Młynarczyk G; Luczak M
    Med Dosw Mikrobiol; 2005; 57(1):1-6. PubMed ID: 16130290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact lens disinfectants.
    Pinna A; Usai D; Zanetti S; Carta F
    Ophthalmology; 2007 Sep; 114(9):1789-90. PubMed ID: 17822984
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in pharmacodynamic studies of antimicrobial resistance.
    Rapp RP; Campion JJ
    Ann Pharmacother; 2003 Sep; 37(9):1329-30. PubMed ID: 12921518
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial activity of enoxacin.
    Nicoletti G; Caccamo F; Speciale A
    J Chemother; 1989 Jul; 1(4 Suppl):143-4. PubMed ID: 16312344
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum.
    Cavalheiro AS; Zanette RA; Spader TB; Lovato L; Azevedo MI; Botton S; Alves SH; Santurio JM
    Vet Microbiol; 2009 Jun; 137(3-4):408-11. PubMed ID: 19269752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in non-tuberculous mycobacteria in New South Wales, 2002-2008.
    Foo H; van Hal S; Jelfs P; Gilbert GL
    Int J Antimicrob Agents; 2009 Aug; 34(2):182-4. PubMed ID: 19285835
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of Staphylococcus spp. to anti-infective agents during the past seven years.
    Higaki S; Kitagawa T; Morohashi M; Yamagishi T
    Int J Antimicrob Agents; 2004 Nov; 24(5):524-5. PubMed ID: 15519493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.